Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10

Citation
F. Batteux et al., Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10, EUR J IMMUN, 29(3), 1999, pp. 958-963
Citations number
18
Categorie Soggetti
Immunology
Journal title
EUROPEAN JOURNAL OF IMMUNOLOGY
ISSN journal
00142980 → ACNP
Volume
29
Issue
3
Year of publication
1999
Pages
958 - 963
Database
ISI
SICI code
0014-2980(199903)29:3<958:CTOEAT>2.0.ZU;2-Z
Abstract
The autoimmune response in experimental autoimmune thyroiditis (EAT) is cha racterized by a lymphocyte infiltration of the thyroid gland and by the app earance of circulating autoantibodies to thyroglobulin (Tg). Cytokines play a crucial role in the immunoregulation and pathology of EAT. Systemic admi nistration of IL-10 has curative effects on EAT, but requires high doses an d iterative injections due to the rapid turnover of this molecule. We have designed an original in vivo gene transfer using a mixture of liposomes and poly-L-Lysine that greatly enhanced the transfection yield, and induced a fast and long-lasting expression of IL-10 on mouse thyroid follicular cells (TFC). IL-10 expression on TFC of mice wit EAT dramatically wipe out the l ymphocytic infiltration in the thyroids. A significant diminution in the pr oliferative anti-Tg T cell response was observed, along with a trend toward s a Th2 response characterized by decreased production of IFN-gamma and by increased anti-Tg IgG1/IgG2a Ab ratios. In conclusion, local IL-10 gene the rapy using non-viral vectors is a novel and promising approach for the trea tment of thyroid autoimmune disorders.